A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation
この論文をさがす
説明
A 45-year-old woman was referred to our hospital with acute renal failure and pyrexia. In August 2005, the patient was diagnosed with IgA-λ type multiple myeloma with chromosome 13 deletion, and received three cycles of vinclistine, adriamycin and dexamethasone followed by high-dose melphalan-based autologous peripheral stem cell transplantation: this resulted in remission 2 months before admission to our hospital. Serum IgA concentration was within the normal limit, but an excess of myeloma cells in bone marrow was confirmed. Immunoelectrophoresis revealed BJP-λ production with no IgA-λ. The patient received several courses of chemotherapy with mechanical ventilation and regular hemodialysis. The progression of the illness was rapid: multiple organ failure promptly developed and the patient died 2 months after admission. Autopsy revealed deposition of light chain λ protein in multiple organs. We report this unusual case of aggressive myeloma recognized shortly after successful autologous transplantation.
収録刊行物
-
- International Journal of Hematology
-
International Journal of Hematology 92 531-534, 2010-08-20
Springer Science and Business Media LLC
- Tweet
キーワード
- Peripheral Blood Stem Cell Transplantation
- Chromosomes, Human, Pair 13
- Fever
- Remission Induction
- Chromosome Disorders
- Acute Kidney Injury
- Middle Aged
- Transplantation, Autologous
- Dexamethasone
- Doxorubicin
- Vincristine
- Antineoplastic Combined Chemotherapy Protocols
- Humans
- Female
- Chromosome Deletion
- Multiple Myeloma
- Melphalan